How to Buy Victoza: Prescription Rules for Liraglutide

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub guide looks at Victoza specifically — the once-daily liraglutide brand that predates the weekly injectables most people picture when they think GLP-1. Browse all Peptides & GLP-1 education

People searching "how to buy Victoza" are usually weighing an older, daily GLP-1 option. Here is the practical picture: what the brand is, how liraglutide works, what it treats, how daily dosing feels, and what the prescription costs.

Victoza: the once-daily liraglutide brand

Victoza is Novo Nordisk's brand of liraglutide — a once-daily GLP-1 receptor agonist FDA-approved for type 2 diabetes in 2010, with a cardiovascular indication added in 2017. Liraglutide shares 97% sequence homology with native human GLP-1, and its daily dosing schedule distinguishes it from the once-weekly injectables that dominate more recent GLP-1 discussion.

How liraglutide engages the GLP-1 receptor

Liraglutide activates the GLP-1 receptor across the pancreas, hypothalamus, and gastrointestinal tract, slowing gastric emptying, softening post-meal glucose rises, curbing appetite, and reinforcing satiety. Because it is a single GLP-1 agonist, it does not engage the GIP receptor the way a dual agonist such as tirzepatide does. Once-daily dosing maintains sustained receptor engagement.

Once-daily versus once-weekly dosing

The practical trade-off with Victoza is its schedule. A once-daily injection means a steady daily routine rather than a single weekly dose, which some patients prefer for predictability and others find less convenient than newer weekly options. Neither approach is inherently better; the right fit depends on the clinical goal, tolerability, and how a routine fits your life.

What Victoza is approved to treat

Victoza is FDA-approved for type 2 diabetes and cardiovascular risk reduction in adults with type 2 diabetes. Across the wider class, approved uses also include chronic weight management (Wegovy, Saxenda, Zepbound) and obstructive sleep apnea in adults with obesity (Zepbound, 2024). Prescribing follows each brand's labeled indication, and the same molecule under a different brand is not automatically interchangeable for coverage.

Daily-dosing tolerability and warnings

As with the class, gastrointestinal effects — nausea, vomiting, diarrhea, and constipation — are the most common and tend to be strongest during dose titration. Every FDA-approved GLP-1 carries the class boxed warning for thyroid C-cell tumors observed in rodent studies. Uncommon but serious events include pancreatitis, gallbladder disease, and acute kidney injury during dehydration.

Victoza pricing and the prescription requirement

Victoza is prescription-only, so a legitimate purchase runs through a licensed clinician and pharmacy. FDA-approved branded products in this category typically list at $800–$1,600 per month at U.S. list as of April 2026, with actual cost shaped by insurance coverage, the FDA indication on the prescription, manufacturer savings-card eligibility, and whether a compounded alternative exists through a licensed 503A pathway.

PlexusDx does not sell, distribute, or prescribe Victoza or any therapeutic peptide outside its own Weight Management Protocols (which include semaglutide and tirzepatide). Whichever GLP-1 pathway compound you and your provider discuss, the underlying genetic architecture is the same. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, and MC4R variants that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. Knowing that profile before committing to any protocol is the test before you invest approach — turning guesswork into an informed conversation with your provider.

Related reading on PlexusDx: Victoza for Type 2 Diabetes, Victoza Price, Victoza Alternatives, Victoza Review.

Disclaimer: This article is educational. PlexusDx does not sell, prescribe, or recommend dulaglutide, liraglutide, retatrutide, cagrilintide, or any other therapeutic peptide in this category beyond the semaglutide and tirzepatide products in its Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Start upstream with the genetic context. Take the Precision Peptide Genetic Test to understand the pathway biology that applies across every GLP-1 decision.

Frequently Asked Questions

Is Victoza a daily or weekly injection?

Victoza is a once-daily GLP-1 receptor agonist, which sets it apart from the once-weekly injectables that dominate newer GLP-1 conversation. The liraglutide molecule shares 97% sequence homology with native human GLP-1, and its daily schedule is a defining practical feature when comparing it to weekly options.

What is Victoza approved to treat?

Victoza is FDA-approved for type 2 diabetes and for cardiovascular risk reduction in adults with type 2 diabetes, per its product label. It is not a weight-management brand; your prescribing provider matches Victoza to its labeled indications rather than to uses cleared for other GLP-1 products.

Do I need a prescription to buy Victoza?

Yes. Victoza is prescription-only, so a legitimate purchase requires a licensed clinician to evaluate your history and issue the prescription before a pharmacy dispenses it. Any source offering Victoza without a clinical evaluation falls outside the legal pathway and should be treated as a warning sign.

Can the Precision Peptide Genetic Test tell me if Victoza will work for me?

No. The test does not predict response to Victoza or any specific medication. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology — the upstream context that applies across every GLP-1 pathway compound, not a drug-response prediction.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.